ABOUT
US

AfroCentric is the most diversified healthcare company in Southern Africa.

We are committed to making healthcare more affordable and widely accessible. Our transformed and integrated service offerings enable us to do this by optimising the healthcare value chain. Recently, we have grown our business through acquisitions to position us as a sustainable and leading healthcare Group.

By completing the integration of new acquisitions into our business and leveraging the power of technology to transform client service, we are moving closer to achieving our ultimate goal of transforming healthcare.

ABOUT AFROCENTRIC

LEADERSHIP
REVIEWS

 

CHAIRMAN’S REVIEW

 

CEO’S REVIEW

 

CFO’s REVIEW

 CHAIRMAN’S review

The vital role played by companies within society was receiving growing recognition before the current crisis and must be emphasised even more at this time.

Indeed, all South Africans and South African companies, as patriotic citizens, must continue to band together to enable the country to emerge from the pandemic with a renewed strength and a clear sense of purpose to overcome our mounting challenges.

DR ANNA MOKGOKONG

CHAIRMAN’S REVIEW

 CEO’S review

At the start of 2020, we could not have imagined the widespread impact of a virus yet to be named. Moreover, more than a year and a half on from our first hard lockdown, we find ourselves still in the riptide of the ongoing devastation.

The world needs the COVID-19 vaccines. A global effort has led to the successful development of multiple vaccines, and further cooperation is necessary to enable the optimum roll out of the vaccination process. There was never any doubt that AfroCentric would use the full might of our diversified business to answer this call.

AHMED BANDERKER

CEO’S REVIEW

 CFO’S review

Aligning shareholders earnings and operating profit growth by maximising organic growth opportunities.

The 2021 Financial year will probably in future be known as the most uncertain time to do business in the world due to the changing trading conditions abroad and in South Africa.

HANNES BOONZAAIER

CFO’S REVIEW

OUR
BUSINESS

  • Who we are,
    What we do

  • Where we
    operate

  • Investment
    case

Who we are, What we do

Who we are

AfroCentric is a majority black-owned JSE-listed investment holding company providing services and products to the healthcare sector. The Group was founded in 2008 on the core philosophy of promoting transformation and empowerment.

What we do

Our business is focused on making a sustainable impact in the area we know best – healthcare. We increase access to sustainable, affordable and quality healthcare through our operating subsidiaries by providing health administration, health risk management, and a range of complementary solutions to our medical scheme clients and their members across the healthcare value chain. A primary lever in our strategy is to reduce the cost of healthcare.


WHY WE EXIST

Our purpose

Enhancing the quality of life.

WHERE WE ARE GOING

Our vision

Transforming healthcare.

HOW WE WILL GET THERE

Our mission

To innovate a new integrated model of sustainable healthcare that measurably improves access to quality healthcare.

WHAT IT WILL REQUIRE OF US

Our values
  • Act with integrity and trust
  • Go the extra mile
  • Cultivate uniqueness
  • Thrive together
  • Make a positive difference
WHO WE ARE

Where we operate

Where we operate

We operate in four sub-Saharan African countries

WHO WE ARE

Investment case

Investment case

Our diversified business model and growth strategy enable us to achieve sustainable growth and value creation across the healthcare sector by leveraging our competitive advantages.

Strong market positioning

One of the largest health administration businesses in the South African healthcare sector.

An integrated healthcare business and market leader in managed care.

The largest distributor of chronic medicine to government hospitals and clinics.

Diversified across complementary healthcare services

Diversification makes us more sustainable in a changing healthcare environment.

Pharmaceutical companies contributed 53% in revenue through organic and acquisitive growth, as well as 27% contribution to operating profit.

Our business model enables the Group to optimise healthcare costs to deliver on our mission.

Multiple growth drivers

Positioning start-ups for success.

Digitising to enhance efficiencies and improve client experience.

Maximising our integrated business model.

Partnering with various institutions to deliver value.

Positioning for success in an NHI environment.

INVESTMENT CASE